Richard Bae, MD
Cardiovascular Disease · Cincinnati, OHNPI 1487684676
Payments from drug & device makers
Across 261 payments — averaging $522.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$116K
- W. L. Gore & Associates, Inc.$12K
- Edwards Lifesciences$6K
- Medtronic$2K
- Boston Scientific$178
Across 4 payments — averaging $5046.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$20K
What the payments were for
- Consulting fees$98,22372%
- Speaking & faculty fees$15,30011%
- Travel & lodging$14,30310%
- Food & beverage$8,6366%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 174 | $116,172 |
| W. L. Gore & Associates, Inc. | 4 | $11,610 |
| Edwards Lifesciences | 67 | $6,361 |
| Medtronic | 12 | $2,141 |
| Boston Scientific | 4 | $178 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$34,571
- Mitra Clip system$15,967
- MitraClip System$15,656
- Tricuspid Valve Repair System$11,754
- Product in Development$11,610
- TRICLIP$9,140
- AMPLATZER AMULET$5,608
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$658
- APOLLOTM$436
- NAVITOR$209
- COREVALVE EVOLUT R$135
- ABSOLUTE PRO$118
How this compares
$136,461 in reported general payments places this provider in the 90th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 27 | $28,749 |
| Repatha SureclickEvolocumab | 14 | $20,033 |
| Metoprolol Succinate | 69 | $1,283 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 29 | $615 |
| Atorvastatin Calcium | 52 | $579 |
| SotalolSotalol Hcl | 14 | $512 |
| Amlodipine Besylate | 49 | $408 |
| Lisinopril | 17 | $339 |
| Losartan Potassium | 18 | $326 |
| ClopidogrelClopidogrel Bisulfate | 15 | $236 |
| Rosuvastatin Calcium | 11 | $227 |
| Carvedilol | 16 | $187 |
| Furosemide | 14 | $128 |
| Nitroglycerin | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Cincinnati
- Peter EngelCincinnati$1.2M
- Wojciech MazurCincinnati$508K
- Dylan SteenCincinnati$469K
- Kamal ShemisaCincinnati$418K
- Freidoon GhaziCincinnati$280K
- Anil VermaCincinnati$195K
- Samir KapadiaCleveland$11.1M
- Steven NissenCleveland$5.3M
- Milind DesaiCleveland$5M
- Abraham LincoffCleveland$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.